BNTX: BioNTech Inc. Kompaniya qiymatining sof foydaga nisbati
BioNTech SE narxlar dinamikasi COVID bilan bog'liq daromadlarning keskin kamayishi va onkologik tadqiqotlar atrofidagi noaniqliklar tufayli murakkablashgan. Kompaniyaga tegishli hisobot P/E koeffitsiyenti bozor baholovlarining qisqarishini aks ettiradi, bunda -12.60 darajasi parametrning holatini ko'rsatadi. Bu mRNA texnologiyalariga yo'naltirilgan ulkan xarajatlar va qat'iy patent nazoratlarining natijasidir. Shu bilan birga, bio-zavodlarning modernizatsiyasi yangi immun dorilarini ishlab chiqarish uchun quvvatlarni moslashuvchan qayta konfiguratsiya qilish imkonini beradi.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_BNTX_-_BioNTech-SE_-_PE-Multiple "BNTX: BioNTech SE Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
BioNTech Group (BNTX) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati BioNTech SE|BNTX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati BioNTech Pharma|BNTX - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati BioNTech SE|BNTX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz BioNTech|Tezkor likvidlik biontech.de
- foyda va bozor multiplikatorlari tafsilotlari:
BNTX - Sof foyda|Kompaniya foydasi prognozi BioNTech SE|BNTX - Narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati BioNTech Inc.|BNTX - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati BioNTech SE|BNTX - Eskirish chegirilmasdan oldingi operatsion foyda|So'nggi to'rtta chorak uchun bir aksiya uchun foyda BioNTech|BNTX - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida yillik hisobda bir aksiya uchun foyda o'sishi biontech.de|BNTX - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi BioNTech SE
Kompaniyaning har tomonlama tahlili:biontech.de BNTX
P/E koeffitsiyenti foydaning bir birligining bozor qiymatini belgilaydi va daromadlar doimiy deb hisoblaganda, investitsiyalarning qoplanish muddatini ko'rsatadi. Koeffitsiyentning ortishi kengayish kutayotganini bildiradi, pasayishi esa aktivning qiymati bozorda past baholanganini anglatadi. BioNTech SE (BNTX) kompaniyasining P/E diapazonini tahlil qilish orqali investor bozor BioNTech SE (BNTX) kompaniyasining vaksina ishlab chiqaruvchidan AI texnologiyalari holdingiga aylanishini qanday baholayotganini ko'rishi mumkin. Jori narxlar dinamikasi yangi onkologiya platformalarini R&D tuzilmasiga integratsiya qilish xarajatlarini aks ettirmoqda.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti ABVX (Abivax Corp)|ADMA (ADMA Biologics Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori PTGX (Protagonist Therapeutics Inc)|Biznesning o‘zini qoplash muddati Immunovant Therapeutics (IMVT)|KNSA - Narxning foydaga nisbati|grifols.com (GRFS) - Narx-foyda koeffitsiyenti|Adaptive Biotechnologies Corporation (ADPT) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Celldex Therapeutics Inc|Narx-foyda koeffitsiyenti AUPH|P/E multiplikatori BioCryst Corp|Narxning foydaga nisbati Vera Therapeutics, Inc. (VERA)|dianthustx.com - Narx-foyda multiplikatori|P/E multiplikatori PHVS (Pharvaris)|AbCellera Corp (ABCL) - Kapitalizatsiyaning foydaga nisbati|Tourmaline Corp - P/E multiplikatori|PGEN: Narxning foydaga nisbati|PHAR: P/E multiplikatori|NKTR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Upstream Bio|Kapitalizatsiyaning foydaga nisbati Zenas Bio ZBIO|Narxning foydaga nisbati Immunome Corp (IMNM)|Gossamer Bio Corp. - Narx-foyda multiplikatori|KalVista Pharmaceuticals - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati SEPN (septerna.com)|Pieris Pharmaceuticals, Inc. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Savara Inc|RIGL: P/E multiplikatori|Narx-foyda koeffitsiyenti AnaptysBio Inc.|ATXS (Astria Therapeutics) - P/E multiplikatori|ENGN: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti RAPT (RAPT Therapeutics)|JBIO (aerovatetx.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Aclaris ACRS|Biznesning o‘zini qoplash muddati Kyverna Therapeutics, Inc (KYTX)|Tiziana Life Sciences - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati cabalettabio.com|VTYX: P/E multiplikatori|THTX (Theratechnologies, Inc.) - Narxning foydaga nisbati|Narxning foydaga nisbati Avalo Therapeutics Inc.|Narx-foyda multiplikatori ELDN (Eledon Pharmaceuticals, Inc)|Narx-foyda koeffitsiyenti AGEN (Agenus)|Bozor narxining sof foydaga nisbati CLYM|Zura Bio - Narx-foyda koeffitsiyenti|ATYR: Narx-foyda multiplikatori|ADAG - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati IMA|STTK: P/E multiplikatori|Equillium - Kompaniya qiymatining sof foydaga nisbati|CNTB (Connect Biopharma Holdings) - P/E multiplikatori|P/E multiplikatori Immunic Inc|Narxning foydaga nisbati Atara Biotherapeutics (ATRA)|IFRX (inflarx.de) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET - Narx-foyda koeffitsiyenti|Celularity Corp - P/E multiplikatori|INMB - P/E multiplikatori|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|Kezar Life Sciences Inc - Kompaniya qiymatining sof foydaga nisbati|SABS (SAB Biotherapeutics) - P/E multiplikatori|akaritx.com (AKTX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA - Narx-foyda koeffitsiyenti|IBIO: Narx-foyda koeffitsiyenti|CARM - P/E multiplikatori|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Narx-foyda multiplikatori BOLT|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Aptevo APVO|P/E multiplikatori AIM|Narxning foydaga nisbati ADTX (aditxt.com)|P/E multiplikatori GRI (GRI Bio)|Biznesning o‘zini qoplash muddati XORTX Therapeutics Inc (XRTX)|HIND - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati Revelation Biosciences Corp|Indaptus Therapeutics (INDP) - Narxning foydaga nisbati|Narx-foyda multiplikatori SCNI|Narx-foyda koeffitsiyenti CALI|AFMD (Affimed Therapeutics) - Bozor narxining sof foydaga nisbati|P/E multiplikatori ALLK|HOOK - Kapitalizatsiyaning foydaga nisbati|P/E multiplikatori IGMS (IGM Biosciences)|ITOS - Narx-foyda koeffitsiyenti|Ocean Biomedical - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati TCBP (TC BioPharm (Holdings) Plc)|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
